MarketPeel
Insider Trading Intelligence
JR

Jayson Rieger

VRCA
CEO AND PRESIDENT · VERRICA PHARMACEUTICALS INC. · CIK 0002043558
FILING MIX · LIFETIME100%/0%
BUYS
9
SELLS
0
TOTAL VALUE
$400.1K
COMPANIES
1
ACTIVE SINCE
Nov 2024
HOLDINGS NOW
512,269
AVG SELL PX
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 7 pending
Forward-return performance of every backtestable P/S trade by Jayson Rieger, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+100.00%+29.80%+1.09%+28.71%+27.53%
14d5+100.00%+25.55%+1.72%+23.83%-0.51%
30d5+40.00%+7.52%+1.03%+6.49%-29.46%
60d5+40.00%+0.93%+1.81%-0.88%-30.01%
90d5+40.00%-11.41%+2.14%-13.55%-28.24%
180d5+40.00%-15.47%-1.50%-34.45%-34.45%
1y5(2 pending)+0.00%-57.67%+11.37%-69.04%-69.04%
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VRCA · 512,269 shares · as of Jun 5, 2026
0500,0001,000,0001,500,0002,000,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
2026
FLOW · 9 buys / 0 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
512,269512,269Jun 5, 2026Jun 9, 2026View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
CEO and President
23,57723,577Nov 25, 2025Nov 25, 2025View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
CEO and President
94,311$4.24$400.1K182,593Nov 25, 2025Nov 25, 2025View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
850,000850,000Mar 14, 2025Mar 18, 2025View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASEGRANT
Gift
50,000882,826Nov 26, 2024Nov 26, 2024View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
CEO and President
140,449140,449Nov 22, 2024Nov 26, 2024View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
CEO and President
280,898832,826Nov 22, 2024Nov 26, 2024View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASE
CEO and President
140,449140,449Nov 22, 2024Nov 26, 2024View →
VRCA
VERRICA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
2,000,0002,000,000Nov 6, 2024Nov 6, 2024View →
Other insiders · VRCA
Loading peer insiders…
About this filer
CIK 0002043558
ROLE
CEO and President
PRIMARY
VRCA
COMPANIES
1
ACTIVE SINCE
Nov 2024
MARKETPEEL · /INSIDER/0002043558DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback